The SLE-DAS provides an accurate and feasible flare tool in the clinical setting: a validation study.

Liliana SaraivaRita N CunhaDiogo JesusMariele GattoMargherita ZenLuca IaccarinoJosé A P da SilvaAndrea DoriaLuís Sousa Inês

Published in: Rheumatology (Oxford, England) (2023)

The SLE-DAS accurately identifies and categorizes flares as mild or moderate/severe. It is feasible and, thus, may help the physicians' treatment decisions in the clinical practice setting.

Keyphrases

disease activity
systemic lupus erythematosus
rheumatoid arthritis
clinical practice
primary care
early onset
high resolution
genome wide
combination therapy
smoking cessation